Raw data could be open / transparent / shared in pharmaceutical (or all) research studies
By Hicbd
Mon Sep 5 2022 10:42 am
"Data sharing would lead to tremendous benefits for patients, progress in science, and rational use of healthcare resources based on evidence we can trust. The harmful consequences are minor compared to the benefits. It has been amply documented that the current situation, with selective reporting of favorable research and biased data analyses being the norm rather than the exception, is harmful to patients and has led to the death of tens of thousands of patients that could have been avoided."
URL:----------------------------------------------------------
Please login to comment
